Back to Search Start Over

An Overview on COVID-19 and its Effect on Cardiovascular Diseases

Authors :
Denise E. Jackson
Abdulrahim R. Hakami
M. I Sayyed
Abdullah Hamadi
Fawaz Yahya Hamdi
Ali Mahzari
Gasim Dobie
Mohammed H Nahari
Salwa Hindawi
Source :
Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:1949-1953
Publication Year :
2021
Publisher :
Bentham Science Publishers Ltd., 2021.

Abstract

Abstract:: COVID-19 (Virus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) is a pandemic disease characterized with respiratory infection caused by coronavirus. It has worldwide after an outbreak began in Wuhan, China, in December 2019. SARS-CoV-2 has infected more than 15 million people globally. The disease severity and mortality increased in patients with heart-related comorbidities. Cardiovascular disease patients are more susceptible and infected with SARS-CoV-2. Early screening and managements these patients prevent or ameliorate adverse outcomes. Several treatments have been used to combat these effects as previously seen in MERS and SARS. This review will cover the association of cardiovascular diseases with COVID 19. It showed that cardiovascular diseases are common in patients with COVID- 19. Increased attention to highlight the gaps should be paid to the care of this unique group of patients.

Details

ISSN :
18715303
Volume :
21
Database :
OpenAIRE
Journal :
Endocrine, Metabolic & Immune Disorders - Drug Targets
Accession number :
edsair.doi.dedup.....55c7e87732f072a51e604da481892180